Table 2. Clinical manifestations, Radiologic characters and laboratory findings of the patients.
No. of patients (%) | |
---|---|
Clinical manifestations | |
Fever | 56 (81%) |
Cough | 39 (56%) |
Dyspnea | 24 (35%) |
Radiologic characters (CT scanning) | |
Ground glass opacity (GGO) | 56 (81%) |
Reticulation | 36 (52%) |
Lymph node enlargement | 25 (36%) |
Patchy scattered infiltrates and parenchymal consolidations | 22 (32%) |
Pleural infusion | 17 (25%) |
Interlobular septa thicken | 16 (23%) |
Nodular consolidations | 10 (14%) |
Pneumothorax | 5 (7%) |
Cystic lesions | 2 (3%) |
Laboratory findings | |
WBC count, cell/μl, mean ±SD | 7335±4528 |
Lymphocytes, cell/μl, mean ±SD | 529±661 |
CD4+ T cell, cell/μl | 169±196 |
Albumin, g/L, mean ±SD | 30±4 |
Serum IgG, g/L, mean ±SD | 9.44±5.24 |
Serum IgA, g/L, mean ±SD | 1.90±0.75 |
Serum IgM, g/L, mean ±SD | 1.02±0.43 |
LDH, U/L | 477±145 |
PaO2/FiO2 ratios, mean ±SD | 217±98 |
Co-infections | 24(34%) |
Cytomegalovirus DNA PCR positive | 13(19%) |
Bacterium in BAL* | 5(7%) |
Aspergillus in BAL | 7(10%) |
* Included pseudomonas aeruginosa in three specimens, Acinetobacter baumannii in one specimen, Klebsiella pneumonia in one specimen